Study finds TB strains in Russia becoming both more resistant to drugs and faster evolving

January 27, 2014 by Bob Yirka report
M. tuberculosis bacterial colonies. Credit: Centers for Disease Control and Prevention.

(Medical Xpress)—An international team of researchers has found that bacteria responsible for Tuberculosis (TB) are becoming more resistant to drugs in Russia than are strains in other parts of the world. In their paper published in the journal Nature Genetics, the team describes how they collected TB isolates from 2,348 people and sequenced the genomes of 1000 of them. In so doing they discovered that not only are many of the strains becoming resistant to drugs meant to disable them, but they have evolved in a way that allows them to overcome antibacterial agents' tendency to cause a slowdown in cell division.

The breakup of the Soviet Union had a lot of political and economic impact on the world, and more and more scientists are finding it also had an impact on the spread of TB—second only to HIV as a leading cause of death from an infectious disease. As the Union fell apart, so too did part of the medical establishment, which led to many patients with TB not getting full treatment—partial treatment oftentimes leads to an increase in resistance as bacteria that are not sufficiently impacted produce stronger offspring. Prior research has suggested that resistant strains have become prevalent in Russia, and now this new study suggests how serious the problem has become. The researchers found nearly half of all isolates tested were resistant to many antibacterial agents—they suffered no harm from at least two of the so-called first line types of drugs. Worse perhaps, they also found that 16 percent of that group was also impervious to so-called second line types of drugs. Treating such patients is both difficult and expensive, and presents a challenge to other nations as people travel to other places.

Drugs for stopping TB don't necessarily kill the bacteria, instead, they disrupt how they function, making it impossible for them to move around, for example, or to reproduce—most cause them to divide more slowly as well. Sadly, the researchers found that several strains in Russia have evolved to overcome this problem as well, and are now able to divide as fast as ever after exposure to antibacterial agents.

Overall, it appears the researchers report, that TB strains in Russia are developing resistance to in general and are evolving into whole new strains that are becoming increasingly difficult to control. Fortunately, all is not lost, they add, noting that as Russia's health system gains strength, so too will the effectiveness of treatment, slowing resistance trends and reducing infection rates, bringing them back into line with most other developed countries.

Explore further: Sequencing tuberculosis strain genomes

More information: Evolution and transmission of drug-resistant tuberculosis in a Russian population, Nature Genetics (2014) DOI: 10.1038/ng.2878

Abstract
The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.

Related Stories

Sequencing tuberculosis strain genomes

December 6, 2013
(Medical Xpress)—The use of whole genome sequencing to identify different strains of bacteria which cause tuberculosis may unlock the door to improved treatments and more accurate clinical trials, according to a new international ...

Probe highlights risk from South Africa's drug-resistant TB

January 17, 2014
A long-term probe has found that South Africans with highly drug-resistant TB are "systematically" discharged from hospital without being cured, placing themselves and others at risk, its authors said Friday.

Drug resistance-associated genes: A cornerstone for the control and protection against tuberculosis

September 5, 2013
BGI in collaboration with Institute of Biophysics, Chinese Academy of Sciences, and other Chinese institutes, have completed the genome sequencing of 161 Mycobacterium tuberculosis that can cause an infectious disease tuberculosis ...

International study reveals alarming levels of extensively drug-resistant tuberculosis

August 29, 2012
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to ...

Improving detection of drug-resistant tuberculosis

May 2, 2012
(Medical Xpress) -- European researchers are developing new assays to detect drug resistant strains of Mycobacterium tuberculosis.

Research reveals new drug target urgently needed for tuberculosis therapy

December 20, 2012
One third of the world is infected with the bacterium that causes tuberculosis (TB), a disease that is increasingly difficult to treat because of wide spread resistance to available drugs. Researchers from the Institute of ...

Recommended for you

Gene variant activity is surprisingly variable between tissues

August 21, 2017
Every gene in almost every cell of the body is present in two variants called alleles—one from the mother, the other one from the father. In most cases, both alleles are active and transcribed by the cells into RNA. However, ...

Genome analysis with near-complete privacy possible, say researchers

August 17, 2017
It is now possible to scour complete human genomes for the presence of disease-associated genes without revealing any genetic information not directly associated with the inquiry, say Stanford University researchers.

Science Says: DNA test results may not change health habits

August 17, 2017
If you learned your DNA made you more susceptible to getting a disease, wouldn't you work to stay healthy?

Genetic variants found to play key role in human immune system

August 16, 2017
It is widely recognized that people respond differently to infections. This can partially be explained by genetics, shows a new study published today in Nature Communications by an international collaboration of researchers ...

Active non-coding DNA might help pinpoint genetic risk for psychiatric disorders

August 16, 2017
Northwestern Medicine scientists have demonstrated a new method of analyzing non-coding regions of DNA in neurons, which may help to pinpoint which genetic variants are most important to the development of schizophrenia and ...

Phenotype varies for presumed pathogenic variants in KCNB1

August 16, 2017
(HealthDay)—De novo KCNB1 missense and loss-of-function variants are associated with neurodevelopmental disorders, with or without seizures, according to a study published online Aug. 14 in JAMA Neurology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.